Canada vs Singapore: Antimicrobial resistance or decreased susceptibiity (DS/R) to
Canada
8.12
in 2022
Singapore
9.68
in 2022
Canada rank
31st
Singapore rank
28th
Antimicrobial resistance or decreased susceptibiity (DS/R) to over time
- Canada
- Singapore
How they compare
Singapore currently reports 9.68 against 8.12 in Canada, a difference of 1.56.
That makes Singapore's figure about 1.2 times Canada's.
The two have swapped places 1 time across 7 shared years of data; in 2014 it was Canada ahead.
Canada ranks 31st and Singapore ranks 28th of 54 countries.
Across the 2 decades both report, Canada averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Canada | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.78 | 2.28 | 4.5 | Canada |
| 2020s | 7.11 | 11.29 | 4.18 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antimicrobial resistance or decreased susceptibiity (ds/r) to, Canada or Singapore?
- Singapore, at 9.68 against 8.12 in Canada as of 2022.
- What is the difference in antimicrobial resistance or decreased susceptibiity (ds/r) to between Canada and Singapore?
- 1.56, with Singapore ahead.
- How many years of comparable data are there for Canada and Singapore?
- 7 years are reported by both, from 2014 to 2022.
- How do Canada and Singapore rank globally for antimicrobial resistance or decreased susceptibiity (ds/r) to?
- Canada ranks 31st and Singapore ranks 28th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion). Statizoid refreshes it automatically from the source and publishes the full history for both places.